Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: A comparative analysis on clinical and prognostic insights

Marco Guazzi, Kenneth Dickstein, Marco Vicenzi, Ross Arena

Research output: Contribution to journalArticle

Abstract

Background-The six-minute walk test (6MWT) and cardiopulmonary exercise testing (CPET) are the 2 testing modalities most broadly used for assessing functional limitation in patients with heart failure (HF). A comprehensive comparison on clinical and prognostic validity of the 2 techniques has not been performed and is the aim of the present investigation. Methods and Results-Two hundred fifty-three patients diagnosed with systolic (n=211) or diastolic (n=42) HF (age: 61.9± 10.1 years; New York Heart Association Class: 2.2±0.78) underwent a 6MWT and a symptom-limited CPET evaluation and were prospectively followed up. During the 4-year tracking period, there were 43 cardiac-related deaths with an annual cardiac mortality rate of 8.7%. The 6MWT distance correlated with CPET-derived variables (ie, peak Vo2, Vo2 at anaerobic threshold, and Ve/Vco2 slope) and was significantly reduced in proportion with lower peak Vo2 and higher Ve/Vco2 slope classes and presence of an exercise oscillatory breathing (EOB) pattern (P2 slope (entire population with HF and patients with a 6MWT≤300 m). Conclusions-The 6MWT is confirmed to be a simple and reliable first-line test for quantification of exercise intolerance in patients with HF. However, there is no supportive evidence for its use as a prognostic marker in alternative to or in conjunction with CPET-derived variables.

Original languageEnglish
Pages (from-to)549-555
Number of pages7
JournalCirculation: Heart Failure
Volume2
Issue number6
DOIs
Publication statusPublished - Nov 2009

Fingerprint

Heart Failure
Exercise
Breathing Exercises
Anaerobic Threshold
Exercise Test
Mortality
Walk Test
Population

Keywords

  • Exercise
  • Heart failure
  • Prognosis
  • Ventilation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure : A comparative analysis on clinical and prognostic insights. / Guazzi, Marco; Dickstein, Kenneth; Vicenzi, Marco; Arena, Ross.

In: Circulation: Heart Failure, Vol. 2, No. 6, 11.2009, p. 549-555.

Research output: Contribution to journalArticle

@article{5d656f9531104a8e9177c4373cb4d68f,
title = "Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: A comparative analysis on clinical and prognostic insights",
abstract = "Background-The six-minute walk test (6MWT) and cardiopulmonary exercise testing (CPET) are the 2 testing modalities most broadly used for assessing functional limitation in patients with heart failure (HF). A comprehensive comparison on clinical and prognostic validity of the 2 techniques has not been performed and is the aim of the present investigation. Methods and Results-Two hundred fifty-three patients diagnosed with systolic (n=211) or diastolic (n=42) HF (age: 61.9± 10.1 years; New York Heart Association Class: 2.2±0.78) underwent a 6MWT and a symptom-limited CPET evaluation and were prospectively followed up. During the 4-year tracking period, there were 43 cardiac-related deaths with an annual cardiac mortality rate of 8.7{\%}. The 6MWT distance correlated with CPET-derived variables (ie, peak Vo2, Vo2 at anaerobic threshold, and Ve/Vco2 slope) and was significantly reduced in proportion with lower peak Vo2 and higher Ve/Vco2 slope classes and presence of an exercise oscillatory breathing (EOB) pattern (P2 slope (entire population with HF and patients with a 6MWT≤300 m). Conclusions-The 6MWT is confirmed to be a simple and reliable first-line test for quantification of exercise intolerance in patients with HF. However, there is no supportive evidence for its use as a prognostic marker in alternative to or in conjunction with CPET-derived variables.",
keywords = "Exercise, Heart failure, Prognosis, Ventilation",
author = "Marco Guazzi and Kenneth Dickstein and Marco Vicenzi and Ross Arena",
year = "2009",
month = "11",
doi = "10.1161/CIRCHEARTFAILURE.109.881326",
language = "English",
volume = "2",
pages = "549--555",
journal = "Circulation: Heart Failure",
issn = "1941-3297",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure

T2 - A comparative analysis on clinical and prognostic insights

AU - Guazzi, Marco

AU - Dickstein, Kenneth

AU - Vicenzi, Marco

AU - Arena, Ross

PY - 2009/11

Y1 - 2009/11

N2 - Background-The six-minute walk test (6MWT) and cardiopulmonary exercise testing (CPET) are the 2 testing modalities most broadly used for assessing functional limitation in patients with heart failure (HF). A comprehensive comparison on clinical and prognostic validity of the 2 techniques has not been performed and is the aim of the present investigation. Methods and Results-Two hundred fifty-three patients diagnosed with systolic (n=211) or diastolic (n=42) HF (age: 61.9± 10.1 years; New York Heart Association Class: 2.2±0.78) underwent a 6MWT and a symptom-limited CPET evaluation and were prospectively followed up. During the 4-year tracking period, there were 43 cardiac-related deaths with an annual cardiac mortality rate of 8.7%. The 6MWT distance correlated with CPET-derived variables (ie, peak Vo2, Vo2 at anaerobic threshold, and Ve/Vco2 slope) and was significantly reduced in proportion with lower peak Vo2 and higher Ve/Vco2 slope classes and presence of an exercise oscillatory breathing (EOB) pattern (P2 slope (entire population with HF and patients with a 6MWT≤300 m). Conclusions-The 6MWT is confirmed to be a simple and reliable first-line test for quantification of exercise intolerance in patients with HF. However, there is no supportive evidence for its use as a prognostic marker in alternative to or in conjunction with CPET-derived variables.

AB - Background-The six-minute walk test (6MWT) and cardiopulmonary exercise testing (CPET) are the 2 testing modalities most broadly used for assessing functional limitation in patients with heart failure (HF). A comprehensive comparison on clinical and prognostic validity of the 2 techniques has not been performed and is the aim of the present investigation. Methods and Results-Two hundred fifty-three patients diagnosed with systolic (n=211) or diastolic (n=42) HF (age: 61.9± 10.1 years; New York Heart Association Class: 2.2±0.78) underwent a 6MWT and a symptom-limited CPET evaluation and were prospectively followed up. During the 4-year tracking period, there were 43 cardiac-related deaths with an annual cardiac mortality rate of 8.7%. The 6MWT distance correlated with CPET-derived variables (ie, peak Vo2, Vo2 at anaerobic threshold, and Ve/Vco2 slope) and was significantly reduced in proportion with lower peak Vo2 and higher Ve/Vco2 slope classes and presence of an exercise oscillatory breathing (EOB) pattern (P2 slope (entire population with HF and patients with a 6MWT≤300 m). Conclusions-The 6MWT is confirmed to be a simple and reliable first-line test for quantification of exercise intolerance in patients with HF. However, there is no supportive evidence for its use as a prognostic marker in alternative to or in conjunction with CPET-derived variables.

KW - Exercise

KW - Heart failure

KW - Prognosis

KW - Ventilation

UR - http://www.scopus.com/inward/record.url?scp=77953680227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953680227&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.109.881326

DO - 10.1161/CIRCHEARTFAILURE.109.881326

M3 - Article

C2 - 19919979

AN - SCOPUS:77953680227

VL - 2

SP - 549

EP - 555

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

SN - 1941-3297

IS - 6

ER -